title: Longitudinal increases in mitochondrial DNA levels in blood cells are associated with survival in critically ill patients.
abstract: BACKGROUND
  Mitochondrial dysfunction may be causally related to the pathogenesis of organ failure in critically ill patients. Decreased mitochondrial DNA (mtDNA) levels have been associated with mitochondrial dysfunction and were investigated here in relation to short-term (31-day) survival.
  
  
  METHODS
  This was a prospective longitudinal cohort study of 28 mechanically ventilated critically ill adults admitted to a single center tertiary care intensive care unit (ICU) with hypotension secondary to cardiogenic (N = 13), septic (N = 14) or hypovolemic (N = 1) disease processes. Clinical data and blood were collected at baseline and patients were followed until they expired or left the ICU. Blood was collected every Monday, Wednesday and Friday, and the buffycoat relative mtDNA/nuclear DNA (nDNA) ratio was determined. An archived pool of healthy controls was also studied.
  
  
  RESULTS
  At baseline, the patients' mtDNA/nDNA ratio was 30% lower than a pool of 24 healthy controls (0.76 versus 1.09) and was not different between short-term survivors and non-survivors (0.74 +/- 0.05 (N = 16) versus 0.79 +/- 0.06 (N = 12), p = 0.49). By day 4, the percent mtDNA/nDNA change from baseline in survivors was significantly different from that in non-survivors (+29.5% versus -5.7%, p = 0.03). It also tended to be higher in survivors at last measurement (+38.4% versus +7.1%, p = 0.06). There was a weak correlation between within patient mtDNA/nDNA and platelet count (r = 0.20, p = 0.03) but not with Sequential Organ Failure Assessment (SOFA) scores (r = 0.12, p = 0.23). The mtDNA associations remained after adjustment for platelet.
  
  
  CONCLUSIONS
  Blood mtDNA levels appeared initially low, increased over time in patients who ultimately survived, and remained low in those who did not. This is consistent with mitochondrial recovery being associated with survival and warrants further investigation as a marker of mitochondrial alterations and outcome in critical illness.
authors: Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada V6T 2B5. helene.cote@ubc.ca
authors: Hélène C F
authors: HC
authors: Côté
authors: Andrew G
authors: AG
authors: Day
authors: Daren K
authors: DK
authors: Heyland
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D001773:Blood Cells / Q000378:metabolism*; D002170:Canada / Q000453:epidemiology; D015331:Cohort Studies; D016638:Critical Illness / Q000401:mortality*; D004272:DNA, Mitochondrial / Q000097:blood*; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D011446:Prospective Studies; D016019:Survival Analysis
chemical_list: D015415:Biomarkers; D004272:DNA, Mitochondrial
references: N Engl J Med. 2002 Mar 14;346(11):811-20
references: 11893792
references: Intensive Care Med. 1999 Jul;25(7):686-96
references: 10470572
references: JPEN J Parenter Enteral Nutr. 2007 Mar-Apr;31(2):109-18
references: 17308251
references: Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5618-23
references: 15800038
references: Am J Respir Crit Care Med. 2003 Feb 15;167(4):570-9
references: 12480607
references: Nucleic Acids Res. 2003 Jun 1;31(11):e61
references: 12771225
references: Curr Infect Dis Rep. 2003 Oct;5(5):365-371
references: 13678565
references: Crit Care Med. 2002 Feb;30(2):276-84
references: 11889292
references: Science. 1964 Mar 27;143(3613):1457-9
references: 14107454
references: Curr Biol. 2001 Mar 6;11(5):361-5
references: 11267874
references: Crit Care Clin. 2002 Jan;18(1):165-75
references: 11910729
references: Intensive Care Med. 2005 Mar;31(3):327-37
references: 15605227
references: Lancet. 2002 Jul 20;360(9328):219-23
references: 12133657
references: Lancet. 2005 Jan 1-7;365(9453):53-9
references: 15639679
references: Crit Care Med. 2006 Sep;34(9):2439-46
references: 16791110
references: J Am Coll Surg. 2006 Mar;202(3):407-17
references: 16500244
references: Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2006 Sep;18(9):554-7
references: 16959157
references: N Engl J Med. 1994 Jun 16;330(24):1717-22
references: 7993413
references: J Infect Dis. 2003 Jun 15;187(12):1972-6
references: 12792876
references: Eur J Med Res. 2004 Aug 31;9(8):371-7
references: 15337626
references: J Mol Cell Cardiol. 2004 Jan;36(1):141-50
references: 14734056
references: Shock. 2006 Nov;26(5):430-7
references: 17047512
references: Mitochondrion. 2004 Sep;4(5-6):729-41
references: 16120428
references: N Engl J Med. 2001 Nov 8;345(19):1359-67
references: 11794168
references: FASEB J. 2005 Sep;19(11):1531-3
references: 15994412
references: J Cell Physiol. 2007 May;211(2):364-70
references: 17219405
references: Ann N Y Acad Sci. 2002 Apr;959:214-37
references: 11976198
references: Biochem Biophys Res Commun. 1988 Sep 30;155(3):1360-5
references: 3178814
references: Am J Respir Crit Care Med. 1999 Oct;160(4):1347-53
references: 10508827
references: Nature. 2005 Oct 13;437(7061):1032-7
references: 16136080
references: Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E1044-50
references: 16803854
references: Adv Exp Med Biol. 2003;530:725-36
references: 14562771
references: Shock. 1996;6 Suppl 1:S23-6
references: 8828094
references: Biochem Soc Trans. 2004 Dec;32(Pt 6):1070-1
references: 15506967
references: Crit Care Med. 1985 Oct;13(10):818-29
references: 3928249